WA
DERM icon

Wasatch Advisors’s Journey Medical DERM Stock Holding History

Wasatch Advisors’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.2M Buy
2,858,930
+725,560
+34% +$4.14M 0.13% 118
2026
Q1 		$10M Buy
2,133,370
+817,095
+62% +$6.34M 0.07% 129
2025
Q4 		$10.1M Buy
1,316,275
+10,003
+0.8% +$78.4K 0.06% 147
2025
Q3 		$9.3M Buy
1,306,272
+154,213
+13% +$1.12M 0.05% 154
2025
Q2 		$8.27M Buy
1,152,059
+221,456
+24% +$1.53M 0.04% 165
2025
Q1 		$5.49M Buy
+930,603
New +$4.58M 0.03% 182

Other funds holding DERM

PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Wasatch Advisors's DERM Position: Q2 2026 in Review

Wasatch Advisors increased its Journey Medical (DERM) stake by 34% in Q2 2026, buying an estimated $4.14M and bringing the position to 2,858,930 shares worth $20.2M. The position accounts for 0.13% of the portfolio, ranked #118.

Wasatch Advisors first reported a position in DERM in Q1 2025 and has held it in 6 quarters since. 4 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Wasatch Advisors held 2,858,930 shares of Journey Medical worth $20.2M as of Q2 2026.
  • Wasatch Advisors bought 725,560 Journey Medical shares in Q2 2026, an estimated $4.14M.
  • Journey Medical made up 0.13% of Wasatch Advisors's portfolio in Q2 2026, its #118 holding.
  • Wasatch Advisors first reported a position in Journey Medical in Q1 2025 and has held it in 6 quarters since.
  • 4 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Wasatch Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.